| ARCHETYPE ID | openEHR-EHR-CLUSTER.tnm_staging-prostate.v1 |
|---|
| Concept | TNM staging - Prostate cancer (Sixth edition) |
|---|
| Description | TNM Staging classification for prostate cancer (Sixth edition). |
|---|
| Use | Use only for the Sixth edition of TNM prostate classification. |
|---|
| Misuse | Not to be used for other editions of TNM classification.
Not to be to stage transitional cell carcinoma of the prostate. |
|---|
| Purpose | To record the TNM staging classification for prostate cancer (Sixth Edition). |
|---|
| References | American Joint Committee on Cancer. TNM schema files [Internet]. [cited 2009 Jul 27 ]
Available from: http://www.cancerstaging.org/education/tnmschema/tnmschema.html
Greene FL, Page DL, Fleming ID. et al, eds, for the American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
|
|---|
| Copyright | copyright (c) 2009 openEHR Foundation |
|---|
| Authors | Author name: Dr Ian McNicoll
Organisation: Ocean Informatics, United Kingdom
Email: ian.mcnicoll@oceaninformatics.com
Date originally authored: 27/07/2009
|
|---|
| Other Details Language | Author name: Dr Ian McNicoll
Organisation: Ocean Informatics, United Kingdom
Email: ian.mcnicoll@oceaninformatics.com
Date originally authored: 27/07/2009
|
|---|
| Other Details (Language Independent) | - References: American Joint Committee on Cancer. TNM schema files [Internet]. [cited 2009 Jul 27 ]
Available from: http://www.cancerstaging.org/education/tnmschema/tnmschema.html
Greene FL, Page DL, Fleming ID. et al, eds, for the American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
- MD5-CAM-1.0.1: C01843F6E3EA9FAE62C779D985320584
|
|---|
| Keywords | tumour, TNM, malignancy, cancer, staging, classification, grade, grading, stage, lymph node, metastasis, prostate |
|---|
| Lifecycle | AuthorDraft |
|---|
| Language used | en |
|---|
| Citeable Identifier | 1013.1.524 |
|---|
| items | |
|---|
| Clinical (cTNM) | Clinical (cTNM): Clinical TNM pre-treatment classification based on physical examination, imaging and biopsies. |
|---|
| Primary tumour (T) | Primary tumour (T): Clincal assessment of the primary tumour.
- at0.43::TX [Primary tumour cannot be assessed.]
- at0.44::T0 [No evidence of primary tumour.]
- at0.45::T1 [Clinically inapparent tumour not palpable or visible by imaging.]
- at0.46::T1a [Tumour incidental histological finding in 5% or less of tissue resected.]
- at0.47::T1b [Tumour incidental histological finding in more than 5% of tissue resected.]
- at0.48::T1c [Tumour identified by needle biopsy.]
- at0.49::T2 [Tumour confined within prostate.]
- at0.50::T2a [Tumour involves one half of one lobe or less.]
- at0.51::T2b [Tumour involves more than half of one lobe, but not both lobes.]
- at0.52::T2c [Tumour involves both lobes.]
- at0.53::T3 [Tumour extends through the prostatic capsule.]
- at0.54::T3a [Extracapsular extension (unilateral or bilateral).]
- at0.55::T3b [Tumour invades seminal vesicle(s).]
- at0.56::T4 [Tumour is fixed or invades adjacent structures other than seminal vesicles: bladder neck, external sphincter, rectum, levator muscles, or pelvic wall.]
|
|---|
| Regional lymph nodes (N) | Regional lymph nodes (N): Clinical assessment of the regional lymph nodes.
- at0.85::NX [Regional nodes cannot be assessed.]
- at0.86::N0 [No metastasis to regional lymph nodes.]
- at0.87::N1 [Metastasis in regional lymph nodes.]
|
|---|
| Distant metastasis (M) | Distant metastasis (M): Clinical assessment of distant metastasis.
- at0.93::MX [Distant metastasis cannot be assessed.]
- at0.94::M0 [No distant metastasis.]
- at0.95::M1 [Distant metastasis present.]
- at0.96::M1a [Metastasis to non-regional lymph nodes.]
- at0.97::M1b [Metastasis to bone(s).]
- at0.98::M1c [Metastasis to other site(s) with or without bone disease.]
|
|---|
| Residual tumour (R) | Residual tumour (R): Clinical assessment of post-treatment residual tumour.
- at0026::RX [Presence of residual tumour cannot be assessed.]
- at0027::R0 [No residual tumour.]
- at0028::R1 [Microscopic residual tumour.]
- at0029::R2 [Macroscopic residual tumour.]
|
|---|
| Clinical staging | Clinical staging: The overall Clinical staging derived from each T, N and M component e.g T1aM0NX. May include additional TNM descriptors. |
|---|
| Clinical stage grouping | Clinical stage grouping: The TNM Clinical stage grouping.
- at0.106::Stage I [T1a,N0,M0,G1]
- at0.107::Stage II [T1a,N0,M0,G2-4; T1b-c,N0,M0,AnyG; T1-2,N0,M0,AnyG]
- at0.108::Stage III [T3,N0,M0,AnyG]
- at0.109::Stage IV [T4,N0,M0,AnyG; AnyT,N1,M0,AnyG; AnyT,AnyN,M1,AnyG]
|
|---|
| Comment | Comment: A text comment on the Clinical staging. |
|---|
| Pathological (pTNM) | Pathological (pTNM): Pathological staging. Based on the clinical staging, results of procedures and pathological/histo-pathological assessment. |
|---|
| Primary tumour (pT) | Primary tumour (pT): Pathological assessment of the primary tumour.
- at0.57::pTX [Primary tumour cannot be assessed.]
- at0.58::pT0 [No evidence of primary tumour.]
- at0.63::pT2 [Tumour confined within prostate.]
- at0.64::pT2a [Tumour involves one half of one lobe or less.]
- at0.65::pT2b [Tumour involves more than half of one lobe, but not both lobes.]
- at0.66::pT2c [Tumour involves both lobes.]
- at0.67::pT3 [Tumour extends through the prostatic capsule.]
- at0.68::pT3a [Extracapsular extension (unilateral or bilateral).]
- at0.69::pT3b [Tumour invades seminal vesicle(s).]
- at0.70::pT4 [Tumour is fixed or invades adjacent structures other than seminal vesicles: bladder neck, external sphincter, rectum, levator muscles, or pelvic wall.]
|
|---|
| Regional lymph node (pN) | Regional lymph node (pN): Pathological assessment of the regional lymph nodes.
- at0.90::pNX [Regional nodes cannot be assessed.]
- at0.91::pN0 [No metastasis to regional lymph nodes.]
- at0.92::pN1 [Metastasis in regional lymph nodes.]
- at0.105::pN1mi [Metastasis to regional nodes no larger than 0.2cm.]
|
|---|
| Distant metastasis (pM) | Distant metastasis (pM): Pathological assessment of distant metastases.
- at0.99::pMX [Distant metastasis cannot be assessed.]
- at0.100::pM0 [No distant metastasis.]
- at0.101::pM1 [Distant metastasis present.]
- at0.102::pM1a [Metastasis to non-regional lymph nodes.]
- at0.103::pM1b [Metastasis to bone(s).]
- at0.104::pM1c [Metastasis to other site(s) with or without bone disease.]
|
|---|
| Residual tumour (pR) | Residual tumour (pR): Pathological assessment of post-treatment residual tumour.
- at0031::pRX [Presence of residual tumour cannot be assessed. ]
- at0032::pR0 [No residual tumour.]
- at0033::pR1 [Microscopic residual tumour.]
- at0034::pR2 [Macroscopic residual tumour.]
|
|---|
| Histopathological grading (G) | Histopathological grading (G): TNM histopathological grading classification.
- at0038::GX [Grade of differentiation cannot be assessed.]
- at0039::G1 [Well differentiated.]
- at0040::G2 [Moderately differentiated.]
- at0041::G3 [Poorly differentiated.]
- at0042::G4 [Undifferentiated.]
|
|---|
| Pathological staging | Pathological staging: The overall Pathological staging derived from each pT, pN and pM component. May include additional TNM descriptors. |
|---|
| Pathological stage grouping | Pathological stage grouping: The TNM Pathological stage grouping.
- at0.110::Stage I [T1a,N0,M0,G1]
- at0.111::Stage II [T1a,N0,M0,G2-4; T1b-c,N0,M0,AnyG; T1-2,N0,M0,AnyG]
- at0.112::Stage III [T3,N0,M0,AnyG]
- at0.113::Stage IV [T4,N0,M0,AnyG; AnyT,N1,M0,AnyG; AnyT,AnyN,M1,AnyG]
|
|---|
| Comment | Comment: A text comment on the Pathological staging. |
|---|
| Other contributors | Heather Leslie Ocean Informatics Australia
Sam Heard Ocean Informatics Australia
Koray Atalag, University of Auckland, New Zealand |
|---|
| Translators | |
|---|